Sponsor Dossier

AbbVie

Sponsor Dossier for AbbVie. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.

About

AbbVie is an Australian Private Company with ABN 48156384262, registered in NSW. The company is Active and operates under the trading names Allergan Aesthetics and AbbVie Pty Ltd.

Portfolio

AbbVie has 36 brands on the ARTG, of which 30 are indexable and 29 carry a Product Information document. 20 brands are PBS-listed, 13 have a PBAC outcome on record, and 13 have an AusPAR on record. Notable brands include ACULAR, ACZONE, ALBALON, ALBALON-A, ALPHAGAN, Aquacare/HP, AQUIPTA, BELKYRA, BOTOX, COMBIGAN, CONSTELLA, DUODOPA.

Therapeutic focus

— Ophthalmology: 16 brands — Oncology: 4 brands — Neurology: 4 brands — Infectious Disease: 3 brands — Dermatology: 3 brands — Immunology: 2 brands — Gastroenterology: 2 brands — Pain & Anaesthesia: 1 brand — Respiratory: 1 brand

PBS footprint

20 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.

Regulatory activity

The latest PBAC outcome is 2026-03-01, across 13 brands with a PBAC outcome on record. The latest AusPAR is 2025-07-29, across 13 brands with an AusPAR on record.

ABR record